Israel Englander Millennium Management
Israel “Izzy” Englander is the founder of Millennium Management, one of the world’s largest multi-strategy hedge fund platforms. Millennium allocates capital across hundreds of independent teams rather than a single house view, with rigorous risk controls at the platform level. Englander’s model has been highly influential in the rise of pod-shop multi-manager structures across the industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Merck
MRK
|
+$216M |
| 2 |
Apple
AAPL
|
+$215M |
| 3 |
KeyCorp
KEY
|
+$212M |
| 4 |
Alphabet (Google) Class A
GOOGL
|
+$210M |
| 5 |
Synchrony
SYF
|
+$204M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
DuPont de Nemours
DD
|
+$1.82B |
| 2 |
Comcast
CMCSA
|
+$427M |
| 3 |
Amazon
AMZN
|
+$418M |
| 4 |
SLB Ltd
SLB
|
+$312M |
| 5 |
Ameren
AEE
|
+$257M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 13.36% |
| 2 | Energy | 10.86% |
| 3 | Financials | 9.53% |
| 4 | Consumer Discretionary | 9.42% |
| 5 | Technology | 9.28% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2926
iShares US Technology ETF
IYW
$24.6B
| $277K | ﹤0.01% |
10,344
-10,072
| -49% | -$272K |
|
|
TTNP
2927
DELISTED
Titan Pharmaceuticals
TTNP
| $277K | ﹤0.01% |
+17
| New | +$277K |
|
|
TESS
2928
DELISTED
Tessco Technologies Inc
TESS
| $277K | ﹤0.01% |
14,234
-15,262
| -52% | -$318K |
|
2929
Enterprise Financial Services Corp
EFSC
$2.3B
| $276K | ﹤0.01% |
9,735
-58,640
| -86% | -$1.65M |
|
2930
Shopify
SHOP
$193B
| $275K | ﹤0.01% |
106,500
-154,630
| -59% | -$455K |
|
2931
Altisource Portfolio Solutions
ASPS
$62.2M
| $274K | ﹤0.01% |
1,233
-2,975
| -71% | -$661K |
|
|
EMCI
2932
DELISTED
EMC INS Group Inc
EMCI
| $274K | ﹤0.01% |
+10,835
| New | +$272K |
|
|
LOXO
2933
DELISTED
Loxo Oncology, Inc
LOXO
| $274K | ﹤0.01% |
+9,624
| New | +$258K |
|
|
JUNO
2934
DELISTED
Juno Therapeutics, Inc.
JUNO
| $274K | ﹤0.01% |
6,236
+536
| +9% | +$26.6K |
|
|
SSE
2935
DELISTED
SEVENTY SEVEN ENERGY INC COM
SSE
| $274K | ﹤0.01% |
261,307
+79,584
| +44% | +$97.5K |
|
|
VRNG
2936
DELISTED
VRINGO, INC COM STK NEW (DE)
VRNG
| $274K | ﹤0.01% |
111,080
-39,330
| -26% | -$129K |
|
2937
Alamos Gold
AGI
$16B
| $273K | ﹤0.01% |
+83,000
| New | +$301K |
|
2938
iShares MSCI Switzerland ETF
EWL
$2.44B
| $272K | ﹤0.01% |
+8,756
| New | +$274K |
|
2939
Genesco
GCO
$390M
| $272K | ﹤0.01% |
4,793
-46,982
| -91% | -$2.72M |
|
|
TSG
2940
DELISTED
The Stars Group Inc.
TSG
| $272K | ﹤0.01% |
+21,626
| New | +$398K |
|
2941
CALL
Freeport-McMoran
FCX
$112B
| $271K | ﹤0.01% |
40,000
| – | – |
|
2942
TFS Financial
TFSL
$4.95B
| $270K | ﹤0.01% |
14,343
-113,796
| -89% | -$2.09M |
|
|
TLGT
2943
DELISTED
Teligent, Inc
TLGT
| $270K | ﹤0.01% |
3,029
+1,027
| +51% | +$82.3K |
|
|
TECD
2944
DELISTED
Tech Data Corp
TECD
| $270K | ﹤0.01% |
4,070
-52,321
| -93% | -$3.73M |
|
|
EXXI
2945
PUT
DELISTED
ENERGY XXI LTD COM SHS
EXXI
| $270K | ﹤0.01% |
267,400
-482,100
| -64% | -$777K |
|
2946
Agilysys
AGYS
$3.21B
| $269K | ﹤0.01% |
26,939
+11,760
| +77% | +$130K |
|
2947
Surgery Partners
SGRY
$1.83B
| $269K | ﹤0.01% |
+13,115
| New | +$251K |
|
|
YUME
2948
DELISTED
YuMe, Inc.
YUME
| $269K | ﹤0.01% |
76,566
+42,066
| +122% | +$130K |
|
2949
iShares MSCI Thailand ETF
THD
$356M
| $268K | ﹤0.01% |
+4,566
| New | +$293K |
|
|
RIGP
2950
DELISTED
Transocean Partners LLC
RIGP
| $268K | ﹤0.01% |
30,400
+7,000
| +30% | +$73.1K |
|
Similar funds
Israel Englander's Q4 2015 Portfolio in Review
As of Q4 2015, Israel Englander held 4,144 positions worth $47.6B, down 7.9% from $51.6B the previous quarter. Its ten largest holdings account for 10% of the portfolio.
Israel Englander withdrew a net $5.89B in Q4 2015, closing 778 positions and reducing 1,349 holdings. Its most notable exit was Illumina, an estimated $86.9M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 13% of assets, up from 13% a quarter earlier, followed by Energy and Financials.
Against the trend, Israel Englander opened a new position in Alphabet (Google) Class A worth $221M.
- Israel Englander's largest Q4 2015 buy was Alphabet (Google) Class A: 5,673,120 shares worth $221M.
- Israel Englander added most to Merck in Q4 2015, an estimated $216M increase.
- Israel Englander's biggest Q4 2015 reduction was DuPont de Nemours, cutting an estimated $1.82B.
- Israel Englander fully exited Illumina in Q4 2015, selling an estimated $86.9M.
- Israel Englander's ten largest holdings make up 10% of its $47.6B portfolio in Q4 2015.
- Israel Englander opened 733 new positions and closed 778 in Q4 2015.
- Israel Englander's portfolio value fell 7.9% quarter-over-quarter to $47.6B.
Based on Millennium Management's 13F filing for Q4 2015, filed 16 Feb 2016.